InsiderTrades.com logo
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"
From Stansberry Research   |   Ad
What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?
Click here to see why experts and insiders may be preparing for the biggest financial crisis of the

NGNE Insider Trading

Insider Ownership Percentage: 9.92%
Insider Buying (Last 12 Months): $1,460,520.00
Insider Selling (Last 12 Months): $0.00

Neurogene Insider Trading History Chart

This chart shows the insider buying and selling history at Neurogene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neurogene Share Price & Price History

Current Price: $22.32
Price Change: ▲ Price Increase of +2.02 (9.95%)
As of 11/25/2024 01:00 AM ET

This chart shows the closing price history over time for NGNE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)
From Investors Alley   |   Ad
140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.
Click now to learn how to have the chance at 140% yields before time runs out!

Neurogene Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2024Christine Mikail CvijicCFOBuy24,000$20.48$491,520.0076,844View SEC Filing Icon  
11/22/2024Rachel McminnCEOBuy47,500$20.40$969,000.001,297,859View SEC Filing Icon  
See Full Table
140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)
From Investors Alley   |   Ad
140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.
Click now to learn how to have the chance at 140% yields before time runs out!

SEC Filings (Institutional Ownership Changes) for Neurogene (NASDAQ:NGNE)

52.37% of Neurogene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NGNE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Neurogene Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC14,859$0.62M0.0%+319.4%0.114%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC220,599$9.26M0.0%-0.7%1.698%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC14,859$0.62M0.0%+319.4%0.114%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC7,717$0.32M0.0%N/A0.059%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP18,290$0.77M0.0%N/A0.141%Search for SEC Filing on Google Icon
11/15/2024State Street Corp246,540$10.35M0.0%+17.5%1.898%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP1,135,256$47.64M0.7%+6.0%8.739%Search for SEC Filing on Google Icon
11/15/2024Redmile Group LLC964,347$40.46M2.4%-4.9%7.424%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC709,469$29.78M0.0%-15.0%5.462%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC44,500$1.87M0.0%-51.9%0.343%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC6,054$0.25M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets2,170$91K0.0%+192.8%0.017%Search for SEC Filing on Google Icon
11/13/2024FMR LLC731,801$30.71M0.0%+912.4%5.634%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.30,317$1.27M0.0%+2.5%0.233%Search for SEC Filing on Google Icon
11/8/2024Jennison Associates LLC78,650$3.30M0.0%N/A0.605%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC1,279$54K0.0%-16.0%0.010%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC3,576$0.15M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC102,187$3.72M0.0%+123.8%0.787%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP41,447$1.51M0.0%+37.2%0.319%Search for SEC Filing on Google Icon
8/14/2024Integral Health Asset Management LLC70,000$2.55M0.2%N/A0.539%Search for SEC Filing on Google Icon
8/14/2024Avoro Capital Advisors LLC22,029$0.80M0.0%N/A0.170%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC52,807$1.92M0.0%-10.0%0.407%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC1,523$55K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers13,489$0.49M0.0%N/A0.104%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp30,428$1.11M0.0%N/A0.234%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC813,353$41.37M0.0%-3.4%6.266%Search for SEC Filing on Google Icon
5/16/2024Redmile Group LLC935,252$47.60M1.7%-1.2%7.205%Search for SEC Filing on Google Icon
5/15/2024Baker BROS. Advisors LP456,015$23.21M0.3%+0.6%3.513%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.507,483$25.83M0.0%+906.5%3.943%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC2,348$0.12M0.0%N/A0.018%Search for SEC Filing on Google Icon
4/30/2024Privium Fund Management UK Ltd5,860$0.27M0.1%N/A0.046%Search for SEC Filing on Google Icon
2/15/2024Great Point Partners LLC994,229$19.27M3.3%N/A42.326%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP466,243$9.04M0.3%N/A19.840%Search for SEC Filing on Google Icon
2/2/2024BML Capital Management LLC24,666$0.48M0.4%N/A1.050%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Neurogene logo
Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York.
Read More on Neurogene

Today's Range

Now: $22.32
Low: $20.53
High: $22.57

50 Day Range

MA: $44.56
Low: $15.33
High: $71.53

52 Week Range

Now: $22.32
Low: $12.49
High: $74.49

Volume

1,297,419 shs

Average Volume

167,243 shs

Market Capitalization

$331.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Neurogene?

Neurogene's top insider investors include:
  1. Rachel Mcminn (CEO)
  2. Christine Mikail Cvijic (CFO)
Learn More about top insider investors at Neurogene.

Who are the major institutional investors of Neurogene?

Neurogene's top institutional investors include:
  1. RTW Investments LP — 8.74%
  2. Redmile Group LLC — 7.42%
  3. FMR LLC — 5.63%
  4. Janus Henderson Group PLC — 5.46%
  5. State Street Corp — 1.90%
  6. Geode Capital Management LLC — 1.70%
Learn More about top institutional investors of Neurogene stock.

Which major investors are selling Neurogene stock?

Within the previous quarter, NGNE stock was sold by these institutional investors:
  1. Janus Henderson Group PLC
  2. Redmile Group LLC
  3. Walleye Capital LLC
  4. Geode Capital Management LLC
  5. Quest Partners LLC

Which major investors are buying Neurogene stock?

Within the last quarter, NGNE stock was bought by institutional investors including:
  1. FMR LLC
  2. Jennison Associates LLC
  3. RTW Investments LP
  4. State Street Corp
  5. Wellington Management Group LLP
  6. Barclays PLC
  7. Barclays PLC
  8. Jane Street Group LLC
Within the previous year, these company insiders have bought Neurogene stock:
  1. Rachel Mcminn (CEO)
  2. Christine Mikail Cvijic (CFO)
Learn More investors buying Neurogene stock.
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"
From Stansberry Research   |   Ad
What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?
Click here to see why experts and insiders may be preparing for the biggest financial crisis of the